<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23389491</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>11</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1179-2027</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24 Suppl 2</Volume>
                    <PubDate>
                        <Year>2006</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PharmacoEconomics</Title>
                <ISOAbbreviation>Pharmacoeconomics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transatlantic convergence with respect to the fourth hurdle?</ArticleTitle>
            <Pagination>
                <MedlinePgn>87-94</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2165/00019053-200624002-00009</ELocationID>
            <Abstract>
                <AbstractText>There appears to be movement towards convergence between the US and Europe in terms of the objectives of prescription drug cost containment, improvement in and more equitable access to pharmaceuticals, and minimisation of variation in clinical practice. In addition, policymakers in the US and Europe are resorting to the use of similar evidence-based approaches to achieve these policy objectives. However, using the examples of clinical practice guidelines, new drug appraisals for reimbursement, reference pricing and prescription to over-the-counter switching, I illustrate how the development and implementation of such approaches are a function not only of evidence but also of politics. Because all politics is local and differs across countries, and settings within countries, this logically has resulted in instances of divergence in the development and implementation of evidence-based approaches. Evidence improves policy decisions by offering quantitative insight into how well new technologies work, and for whom, but such data do not eliminate vexing trade-offs between the benefits provided and the acceptability of risks and costs incurred to achieve those benefits. Judgments on trade-offs depend in part on the interests and values of stakeholders. And these interests and values help shape how policy makers responsible for drug reimbursement in the US and Europe develop and apply the same types of evidence-based approaches differently.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cohen</LastName>
                    <ForeName>Joshua</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tufts Center for Study of Drugs Development, 192 South Street, Suite 550, Boston, Massachusetts 02111, USA. joshua.cohen@tufts.com</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Pharmacoeconomics</MedlineTA>
            <NlmUniqueID>9212404</NlmUniqueID>
            <ISSNLinking>1170-7690</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D055553">Prescription Drugs</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>T</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D003363" MajorTopicYN="N">Cost Control</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016527" MajorTopicYN="N">Drug Costs</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011050" MajorTopicYN="Y">Policy Making</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055553" MajorTopicYN="N">Prescription Drugs</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012051" MajorTopicYN="Y">Reimbursement Mechanisms</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>2</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2006</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23389491</ArticleId>
            <ArticleId IdType="doi">10.2165/00019053-200624002-00009</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Manag Care. 2004 May;10(5):308-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15152700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacoeconomics. 2006 Dec;24 Suppl 2:55-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23389488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2003 May-Jun;22(3):16-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12757268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2005 Jan 1;330(7481):39-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15626806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2005 Jan-Feb;24(1):151-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15647226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2003 May-Jun;22(3):42-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12757270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2004 May-Jun;23(3):10-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15160799</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2005 Jan-Feb;24(1):29-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15647213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-284-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15451997</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Technol Assess Health Care. 2004 Fall;20(4):415-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15609789</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Value Health. 2003 Jul-Aug;6 Suppl 1:S46-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12846925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Ther. 2003 Sep-Oct;10(5):370-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12975722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Oct 11;315(7113):943-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9361548</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
